Previously, lupus‐prone MRL‐lpr mice treated with a low dose of G‐CSF exhibited exacerbated kidney disease with enhanced glomerular deposition of Ig, whereas those on high dose treatment were protected, possibly by local downmodulation of Fc receptor expression in the glomeruli.33 This evidence concerns the gene CSF3 and kidney disorder.